{"title":"整个药物开发生命周期的成本效益分析","authors":"R. Arnold","doi":"10.1002/0471266949.BMC161","DOIUrl":null,"url":null,"abstract":"Cost-effectiveness analysis (CEA) is a systematic, quantitative method for summarizing health benefits and health resources of various treatment options into single numbers or ratios so that policy makers can choose among them. Computer modeling of cost-effectiveness may play a significant role in informing the pharmaceutical decision-making process throughout a product's life cycle, increasing the likelihood of reimbursement and broad use. \n \n \nKeywords: \n \ncost-effectiveness; \ndecision analysis; \neconomics; \nmodeling","PeriodicalId":9514,"journal":{"name":"Burger's Medicinal Chemistry and Drug Discovery","volume":"20 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2010-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost‐Effectiveness Analyses Throughout the Drug Development Life Cycle\",\"authors\":\"R. Arnold\",\"doi\":\"10.1002/0471266949.BMC161\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cost-effectiveness analysis (CEA) is a systematic, quantitative method for summarizing health benefits and health resources of various treatment options into single numbers or ratios so that policy makers can choose among them. Computer modeling of cost-effectiveness may play a significant role in informing the pharmaceutical decision-making process throughout a product's life cycle, increasing the likelihood of reimbursement and broad use. \\n \\n \\nKeywords: \\n \\ncost-effectiveness; \\ndecision analysis; \\neconomics; \\nmodeling\",\"PeriodicalId\":9514,\"journal\":{\"name\":\"Burger's Medicinal Chemistry and Drug Discovery\",\"volume\":\"20 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Burger's Medicinal Chemistry and Drug Discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/0471266949.BMC161\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Burger's Medicinal Chemistry and Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/0471266949.BMC161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cost‐Effectiveness Analyses Throughout the Drug Development Life Cycle
Cost-effectiveness analysis (CEA) is a systematic, quantitative method for summarizing health benefits and health resources of various treatment options into single numbers or ratios so that policy makers can choose among them. Computer modeling of cost-effectiveness may play a significant role in informing the pharmaceutical decision-making process throughout a product's life cycle, increasing the likelihood of reimbursement and broad use.
Keywords:
cost-effectiveness;
decision analysis;
economics;
modeling